Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Lipomed AG, Pharmion deal

Lipomed received exclusive rights from PHRM to distribute Thalidomide Pharmion 50 mg in Switzerland and

Read the full 157 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE